Practice in the Perioperative Prevention of Deep Vein Thrombosis in German Neurosurgical Departments – Is There a Trend Towards Homogenization?

Abstract

Objective: There was no consensus on the most suitable perioperative prophylaxis of deep vein thrombosis (DVT) in neurosurgical patients. The aim of this work was to review the current practice and search for a standard protocol in the prophylaxis of DVT.

Methods and material: Questionnaires addressing the routine prophylaxis of perioperative DVT for 4 groups of neurosurgical procedures and the estimation of risks and benefits of perioperative heparin (unfractionated and/or low-molecular-weight) administration were sent to 130 neurosurgical departments in Germany.

Results: 103 of 130 questionnaires were returned and suitable for analysis. The use of heparin (unfractionated and/or low-molecular-weight) is common, with some variation depending on the type of operation (83.5–99%). In spinal procedures, heparin administration is commonly started early, i. e., between the preoperative and first postoperative day (90.3–97.1%). This differs in intracranial procedures. In most neurosurgical departments heparin administration is stopped at the day of discharge (69.6–77.4% depending on procedure). Enoxaparin is the most commonly used heparin. In spinal as well as in cranial procedures, thrombosis risk reduction is unanimously assumed to be lesser the later administration starts. The estimation of the risks related to heparin injection are considered to be higher in cranial than in spinal operation in the early postoperative period. Most departments use antithrombotic stockings (ATS) irrespective of the type of surgery. However, 11% never use ATS.

Conclusions: In spinal surgery, a trend towards homogenization is observed with the early use of heparin. In intracranial procedures, practice is more heterogenous. The heterogeneity is due to the fact that the data available in the literature does not allow for the identification of an optimal protocol.

Key words

deep vein thrombosis - pulmonary embolism - prophylaxis - heparin - neurosurgery

References

• 1 Agnelli G, Piovella F, Buoncristiani P. et al . Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.  N Engl J Med. 1998;  339 (2) 80-85 Bergqvist D, Eldor A, Thorlacius-Ussing O, Combe S, Cossec-Vion MJ. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group. Br J Surg 1997;84(8):1099–103
• 2 Attia J, Ray JG, Cook DJ. et al . Deep vein thrombosis and its prevention in critically ill adults.  Arch Intern Med. 2001;  161 (10) 1268-1279
• 3 Barnett HG, Clifford JR, Llewellyn RC. Safety of mini-dose heparin administration for neurosurgical patients.  J Neurosurg. 1977;  47 (1) 27-30
• 4 Bergqvist D, Eldor A, Thorlacius-Ussing O. et al . Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.  ENOXACAN Study Group Br J Surg. 1997;  84 (8) 1099-1103
• 5 Dickinson LD, Miller LD, Patel CP. et al . Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors.  Neurosurgery. 1998;  43 (5) 1074-1081
• 6 Frim D, Barker FG, Poletti CE. et al . Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients.  Neurosurgery. 1992;  30 (6) 830-832
• 7 Goldhaber SZ, Dunn K, Gerhard-Herman M. et al . Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis.  Chest. 2002;  122 (6) 1933-1937
• 8 Hamilton MG, Hull RD, Pineo G. Venous thromboembolism in neurosurgery and neurology patients: a review.  Neurosurgery. 1994;  34 (2) 280-296 discussion 296
• 9 Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis.  Arch Intern Med. 2000;  160 (15) 2327-2332
• 10 Kakkar VV, Cohen AT, Edmonson RA. et al . Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery.  The Thromboprophylaxis Collaborative Group Lancet. 1993;  341 (8840) 259-265
• 11 Kleindienst A, Harvey HB, Mater E. et al . Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery.  Acta Neurochir (Wien). 2003;  145 (12) 1085-1090
• 12 Norwood SH, McAuley CE, Berne JD. et al . Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries.  Arch surg. 2002;  137 (6) 696-701
• 13 Nurmohamed MT, Verhaeghe R, Haas S. et al . A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.  Am J Surg. 1995;  169 (6) 567-571
• 14 Paoletti C, Maubec E, Raggueneau JL. et al . [Clinical tolerance of CY 216 (Fraxiparin) in the prevention of thromboembolic accidents after neurosurgery].  Agressologie. 1989;  30 (6) 363-366
• 15 Raabe A, Gerlach R, Zimmermann M. et al . Practice of perioperative thromboembolic prophylaxis in neurosurgery: results of a German survey.  Zentralbl Neurochir. 2000;  61 (2) 103-110
• 16 Raabe A, Gerlach R, Zimmermann M. et al . The risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery.  Acta neurochir (Wien). 2001;  143 (1) 1-7
• 17 Sawaya R, Highsmith RF. Postoperative venous thromboembolism and brain tumors: Part III.  Biochemical profile J Neurooncol. 1992;  14 (2) 113-118
• 18 Stephens PH, Healy MT, Smith M. et al . Prophylaxis against thromboembolism in neurosurgical patients: a survey of current practice in the United Kingdom.  Br J Neurosurgery. 1995;  9 (2) 159-163
• 19 Warkentin TE, Levine MN, Hirsh J. et al . Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.  N Engl J Med. 1995;  332 (20) 1330-1335
• 20 Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux.  N Engl J Med. 2007;  356 (25) 2653-2655
• 21 Weitz JI. Low-molecular-weight heparins.  N Engl J Med. 1997;  337 (10) 688-698

Correspondence